Mallinckrodt and Endo to merge in $6.7bn stock and cash deal
The merger will unite pharmaceutical brands across various therapeutic areas, including XIAFLEX, Acthar Gel, Terlivaz, SUPPRELIN LA, and AVEED
ViiV Healthcare’s N6LS shows promise in long-acting HIV treatment
Emergent invests in Rocketvax to support vaccine development
Vivace secures $35m to advance clinical development of VT3989
Arvinas and Pfizer’s vepdegestrant meets primary endpoint in VERITAC-2 trial
Ono obtains exclusive rights to Ionis’ rare blood disorder treatment
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry